The race in R & D to validate CD 17 ( CHM ), 20,22 is on and human trials are already underway or shortly to commence. If onCARlytics shows the expected efficacy then CF33 can be easily combined with all of them. All eyes on the pre-clinical results with CELU.
GLTA
Ann: Imugene appoints Dr Jakob Dupont as Non-Executive Director, page-13
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.002(3.64%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.3¢ | $521.9K | 9.645M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 749749 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 452962 | 3 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |